Thursday, November 26, 03:42 am IST
| Feedback
Moneycontrol » News Center » Business » Business News
Aurobindo gets approval for Didanosine Delayed Release Cap
Published on Thu, Sep 25, 2008 at 13:52   |  Updated at Thu, Sep 25, 2008 at 15:27  |  Source : Moneycontrol.com

Aurobindo Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Didanosine Delayed Release (Enteric-Coated) Capsules 125mg, 200mg, 250mg and 400mg

 


Didanosine Delayed Release Capsules is the generic version of Bristol Myer Squibb's Videx® EC (Didanosine) Delayed-release Capsules, 125mg, 200mg, 250mg and 400mg and is indicated for the treatment of HIV-1 infections in adults.

 

This is Aurobindo’s 78th ANDA approval from the USFDA 

 

Sourced From: Aurobindo Pharma Limited

More news from Business
Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
WHAT OTHERS LIKE
  • Most Read
  • Most Viewed
24 Hours
7 Days
1 Month
NEWS FROM OUR PARTNERS
©Network 18, 2009. All Rights Reserved